India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives 

28 February 2002

[an error occurred while processing this directive]


WHO to source HIV drugs from India
A WHO-led team comprising of representatives from international aid agencies UNICEF, UNAID, UNFDA and PIC, and Medicins Sans Frontieres is scheduled to hold a formal dialogue with the DCGI and Indian drug companies on May 7 at Delhi to discuss the possibility of sourcing 15 approved HIV/AIDS drugs from India.

Cipla sets its sight on inhalable insulins
Pharma major Cipla has joined a select club of 4-5 international companies that are working to develop inhalable form of insulins.

IMS’ new postulate sets the cat among the pigeons
Vin Khisty, area vice-president - South Asia, IMS Health India, has said aloud what many in the pharmaceutical industry have been whispering since the drug policy 2002 was formally announced.

Express Pharma Pulse
Awards 2002

3 new recognitions this time, totalling 10
Honouring excellence has been our tradition. Or perhaps a habit. Indian pharmaceutical industry is the fourth largest in the world today. The highest of its growth rally was registered in the last one decade.

Coversation

‘Public-private sector coordination needed in TB diagnostics’
Dr Mark D Perkins, science officer with the Global Programme on Tuberculosis in WHO and manager of Diagnostics for the UNDP/ World Bank/ WHO special programme for Research and Training in Tropical Diseases (TDR)

Bio Tech
Enzyme key to toxoplasma pathology
Opening avenues for dvpt of
vaccines and other treatments

IT IN PHARMA

Integrated Solution: For maximizing business prospects
Today the enterprise software and value added services combine to provide the most comprehensive learning solution to help organizations improve productivity and boost business performance through e-Learning, says Prof. P K Gupta

HAPPENINGS
GLOBAL PHARMA
ThinkGen eyes Singapore for bioinformatics hub
IPA organises lecture meet
Workshop on Microwave Synthesis of Bio Active Molecules
Agilent holds seminars on regulation
IDMA East India Chapter initiative on eco friendly tech
Novartis’ Zometa cleared for bone metastases
MMR vaccine is safe: Experts
EMEA to review Glaxo’s Zyban
EU agency backs Johnson & Johnson contraceptive patch Evra
News Briefs
EDITORIAL
TECHNOLOGY TRENDZ

Editorial
A suit-able argument
Edit Article
Biogenerics: Novel opportunities

Rockwell Automation to acquire Propack Data
Forest Pharma upgrades to web-enabled sales force product suite
De Novo, Sun Microsystems to develop chemoinformatics platform
Oracle, Dendrite to enhance clinical trial efficiency

CHENNAI PHARMA SCENARIO
CORPORATE

TN all geared up to implement Schedule T
‘Infantile diarrhoea project will develop diagnostic kits for developing nations’
Seaglad launches Lactoup and Freejoint powder
TN community pharma activity termed a success

Alembic ties up with Cognis for Isovon
Cadila to spread marketing wing to Europe
Lyka approves JV with Hetero

Express Pharma Pulse
Global Pharma
IT in Pharma
Technology Trendz
Corporate Monitor
Happennings
Editorial
Market Place 
Showcase

Scrips

Policies & Amendment
Bulk Drug Prices Trends
Bio Tech
Chennai Pharma Scenario
Conversation

Subscribe
Unsubscribe

 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Exp. Hotelier & Caterer
  Exp. Travel & Tourism
  Exp. Backwaters
  Exp. Healthcare Mgmt.
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express


<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.